Cannabinoid receptor antagonists are compounds that interfere with the endocannabinoid system, a key regulator of various physiological processes. By blocking cannabinoid receptors, these antagonists can impact pain perception, appetite, and immune responses. They are of particular interest in pain management and potential treatment of obesity. Research into these compounds continues to explore their therapeutic potential, addressing the intricate balance of the endocannabinoid system for better health outcomes.